OGI — Organigram Global Share News
0.000.00%
- CA$193.18m
- CA$284.02m
- CA$259.18m
Canada's Organigram Q3 revenue beats on Sanity acquisition; CFO to exit
Brief: Organigram Q3 Revenue CAD 105.782 Million Vs. IBES Estimate CAD 98.8 Million
Brief: Organigram Provides Business Update Highlighting Initial Sanity Performance And Canadian Market Share
Canada cannabis producer Organigram's Q2 net revenue falls more than expected
Explainer: How US marijuana reclassification could help cannabis companies
Explainer: How US marijuana reclassification could help cannabis companies
Explainer: How US marijuana reclassification could help cannabis companies
Brief: Organigram Announces C$65.2 Million Bat Private Placement Investment In Connection With The Acquisition Of Sanity Group
Brief: Organigram Announces Proposed Acquisition Of Sanity Group, A Leading German Cannabis Company
Canadian cannabis firm Organigram's Q1 net revenue jumps 49%
Brief: Organigram Q1 Revenue CAD 63.538 Million Vs. IBES Estimate CAD 73.1 Million
Brief: Organigram Extends Innovation Investment With Phylos
Explainer: How US marijuana reclassification could help cannabis companies
Explainer: How US marijuana reclassification could help cannabis companies
Trump moving to ease US marijuana regulations, sparking industry hopes (updated)
Trump moving to ease US marijuana regulations, sparking industry hopes
Explainer: How US marijuana reclassification could help cannabis companies
Brief: Organigram Announces Appointment Of Chief Executive Officer
Cannabis stocks surge after Trump endorses cannabidiol for senior healthcare (updated)